ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $488.25 million. The enterprise value is $310.21 million.
| Market Cap | 488.25M |
| Enterprise Value | 310.21M |
Important Dates
The last earnings date was Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 302.32 million shares outstanding. The number of shares has increased by 17.54% in one year.
| Current Share Class | 208.93M |
| Shares Outstanding | 302.32M |
| Shares Change (YoY) | +17.54% |
| Shares Change (QoQ) | +31.45% |
| Owned by Insiders (%) | 12.51% |
| Owned by Institutions (%) | 17.01% |
| Float | 154.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 572.86 |
| Forward PS | 834.80 |
| PB Ratio | 2.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 355.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.36, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.36 |
| Quick Ratio | 8.04 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9,327.16 |
Financial Efficiency
Return on equity (ROE) is -58.96% and return on invested capital (ROIC) is -38.85%.
| Return on Equity (ROE) | -58.96% |
| Return on Assets (ROA) | -35.66% |
| Return on Invested Capital (ROIC) | -38.85% |
| Return on Capital Employed (ROCE) | -78.31% |
| Weighted Average Cost of Capital (WACC) | 13.63% |
| Revenue Per Employee | $3,541 |
| Profits Per Employee | -$364,325 |
| Employee Count | 231 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.19% in the last 52 weeks. The beta is 1.72, so ProKidney's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -39.19% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 44.61 |
| Average Volume (20 Days) | 880,247 |
Short Selling Information
The latest short interest is 20.91 million, so 6.92% of the outstanding shares have been sold short.
| Short Interest | 20.91M |
| Short Previous Month | 19.43M |
| Short % of Shares Out | 6.92% |
| Short % of Float | 13.52% |
| Short Ratio (days to cover) | 13.13 |
Income Statement
In the last 12 months, ProKidney had revenue of $818,000 and -$84.16 million in losses. Loss per share was -$0.56.
| Revenue | 818,000 |
| Gross Profit | 818,000 |
| Operating Income | -177.22M |
| Pretax Income | -166.78M |
| Net Income | -84.16M |
| EBITDA | -170.37M |
| EBIT | -177.22M |
| Loss Per Share | -$0.56 |
Balance Sheet
The company has $181.56 million in cash and $3.52 million in debt, with a net cash position of $178.04 million or $0.59 per share.
| Cash & Cash Equivalents | 181.56M |
| Total Debt | 3.52M |
| Net Cash | 178.04M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 222.84M |
| Book Value Per Share | -4.29 |
| Working Capital | 167.06M |
Cash Flow
In the last 12 months, operating cash flow was -$141.17 million and capital expenditures -$18.57 million, giving a free cash flow of -$159.73 million.
| Operating Cash Flow | -141.17M |
| Capital Expenditures | -18.57M |
| Depreciation & Amortization | 6.85M |
| Net Borrowing | -8,000 |
| Free Cash Flow | -159.73M |
| FCF Per Share | -$0.53 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -21,664.55% |
| Pretax Margin | -20,388.39% |
| Profit Margin | n/a |
| EBITDA Margin | -20,827.63% |
| EBIT Margin | -21,664.55% |
| FCF Margin | n/a |
Dividends & Yields
ProKidney does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.54% |
| Shareholder Yield | -17.54% |
| Earnings Yield | -17.96% |
| FCF Yield | -34.09% |
Analyst Forecast
The average price target for ProKidney is $6.25, which is 287.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.25 |
| Price Target Difference | 287.00% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 327.50% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |